Retension Pharmaceuticals, Inc. · NASDAQ:RTSN
Pvg Asset Management Corp reported a 8.30% stake in Retension Pharmaceuticals, Inc. (Schedule 13G)
Event Oct 9, 2026 · Filed Oct 16, 2026
Pvg Asset Management Corp reported a 8.30% stake in Retension Pharmaceuticals, Inc., 1,002,050 shares, as a passive investor on Oct 9, 2026. Filed Oct 16, 2026 (Schedule 13G).
- Stake
- 8.30%
- Shares
- 1,002,050
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| PVG ASSET MANAGEMENT CORP | 8.30% | 1,002,050 |
Source
Download original · View original at SEC
Related
- Retension Pharmaceuticals, Inc.
- Pvg Asset Management Corp
- Retension Pharmaceuticals, Inc. shareholders
- Schedule 13G · B Group, Inc. · Oct 16, 2026
- Schedule 13G · Laurence W. Lytton · Oct 15, 2026
- Schedule 13D · Keller Eric L. · Oct 14, 2026
- Form 4 · Berendt Michael J · Oct 13, 2026
- Form 4 · Berger Franklin M · Oct 13, 2026